California transcatheter mitral valve implantation systems maker CardiAQ Technologies closes a $32.5 million funding round.

Transcatheter valve maker CardiAQ Valve Technologies raised $33.2 million, successfully closing an equity funding round launched late last month.

CardiAQ, a privately held device maker developing transcatheter mitral valve replacement technology, did not disclose the names of investors.